(PubMed) Weston SB, Zhou S, Weatherby RP, Robson SJ
This formulation employs Chiasma Pharmas Transient Permeation Enhancer (TPE) technology, which temporarily and reversibly modulates TJs, particularly by redistributing TJ proteins such as ZO-1 and claudins (Tuvia et al., 2014)
Gastroenterology 2015
Part D beneficiaries must be enrolled in a standalone prescription drug plan (PDP) or a Medicare Advantage (MA) coordinated care plan that offers prescription drug coverage (MA-PD plan)
- Gy au bng, hi, y bng, kh chu d dy: iu ny c th xy ra do protein trong collagen khin h tiu ha phi lm vic nhiu hn phn gii cc protein ln thnh amino acid, hoc do cc thnh phn khc i km vi sn phm collagen khng c h tiu ha hp th tt
This 3-phase system is unique